A.C. van Grootheest
- Toxicology top 0.2%
- Pediatrics, Perinatology and Child Health top 10%
- Geriatrics and Gerontology top 2%
- Economics and Econometrics top 10%
- Pharmacology top 10%
- Co-authors
- Linda HärmarkLolkje T.W. de Jong‐van den BergEugène van PuijenbroekMark de GrootH.E. van der WielG.A.J. DunselmanAnneke PassierLorna Renner
- Topics
- Pharmacovigilance and Adverse Drug Reactions (14 papers)Pharmaceutical studies and practices (5 papers)Pharmaceutical Economics and Policy (4 papers)
- Journals
- British Journal of Clinical PharmacologyDrug SafetyEuropean Journal of Clinical Pharmacology
- Partner nations
- NetherlandsNew ZealandGhana
In The Last Decade
A.C. van Grootheest
21 papers receiving 594 citations
Peers
Comparison fields: 5 of 80
- Toxicology 392
- Pediatrics, Perinatology and Child Health 159
- Geriatrics and Gerontology 152
- Economics and Econometrics 114
- Pharmacology 100
Countries citing papers authored by A.C. van Grootheest
This map shows the geographic impact of A.C. van Grootheest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.C. van Grootheest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.C. van Grootheest more than expected).
Fields of papers citing papers by A.C. van Grootheest
This network shows the impact of papers produced by A.C. van Grootheest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.C. van Grootheest. The network helps show where A.C. van Grootheest may publish in the future.
Co-authorship network of co-authors of A.C. van Grootheest
This figure shows the co-authorship network connecting the top 25 collaborators of A.C. van Grootheest. A scholar is included among the top collaborators of A.C. van Grootheest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.C. van Grootheest. A.C. van Grootheest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 201 | |
| 3 | 0 | |
| 4 | 80 | |
| 5 | 17 | |
| 6 | 5 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | [Bruxism as a side effect of serotonin re-uptake inhibitors]. | 1 |
| 10 | 2 | |
| 11 | 48 | |
| 12 | 79 | |
| 13 | [Direct reporting of side effects by the patient: favourable experience in the first year]. | 31 |
| 14 | Patients' role in reporting adverse drug reactions | 1 |
| 15 | [Severe adverse reactions after the use of sulphur hexafluoride (SonoVue) as an ultrasonographic contrast agent]. | 21 |
| 16 | [Leopold Meyler (1903-1973): a pioneer in the field of side affects of drugs]. | 0 |
| 17 | 4 | |
| 18 | Improving pharmacovigilance and the role of the pharmacist | 11 |
| 19 | 51 | |
| 20 | 63 |
About A.C. van Grootheest
A.C. van Grootheest is a scholar working on Toxicology, Geriatrics and Gerontology and Complementary and Manual Therapy, having authored 23 papers that have together received 633 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (14 papers), Pharmaceutical studies and practices (5 papers) and Pharmaceutical Economics and Policy (4 papers). The work is most often cited by research in Toxicology (392 citations), Geriatrics and Gerontology (152 citations) and Pharmacology (76 citations). A.C. van Grootheest has collaborated with scholars based in Netherlands, New Zealand and Ghana. Frequent co-authors include Linda Härmark, Lolkje T.W. de Jong‐van den Berg, Eugène van Puijenbroek, Mark de Groot, H.E. van der Wiel, G.A.J. Dunselman, Anneke Passier, Lorna Renner, Alexander Dodoo and Jerry Labadie. Their work appears in journals such as British Journal of Clinical Pharmacology, Drug Safety and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.